Press releases
- Bio-Rad Reports First-Quarter 2024 Financial Results
- Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference
- Bio-Rad Announces Life Science Group Management Changes
- Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
- Bio-Rad’s Chief Operating Officer Andrew Last to Retire
- Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer
- Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day
- Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 257.10 |
---|---|
High | 257.10 |
Low | 257.10 |
Bid | 261.70 |
Offer | 263.00 |
Previous close | 250.60 |
Average volume | 4.33 |
---|---|
Shares outstanding | 28.54m |
Free float | 19.99m |
P/E (TTM) | -- |
Market cap | 7.93bn USD |
EPS (TTM) | -10.36 USD |
Data delayed at least 15 minutes, as of May 10 2024 07:03 BST.
More ▼